Skip to main content
All lobbying filings

RK Strategies, Inc.

RK Strategies, Inc. filed a Q1 report for Nexalin Technology Inc. on April 20, 2026, reporting $20,000 in lobbying income.

Lobbying for Nexalin Technology Inc. · Medical Devices - Neurostimulation / Mental Health

As filed: RK STRATEGIES, INC. for NEXALIN TECHNOLOGY INC.

All filings by RK Strategies, Inc. · Everything Nexalin Technology Inc. has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 20, 2026
Income
$20,000
What the client paid this registrant for the period.
Client based in
Texas

Official filing document

 Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 3
Health Issues

H.R. 7091, Expanding Veterans Access to Emerging Treatments Act Military Construction, Veterans Affairs, and Related Agencies Appropriations Bill for FY 2027 National Defense Authorization Act, FY27 Other Appropriations issues

Defense

H.R. 7091, Expanding Veterans Access to Emerging Treatments Act Military Construction, Veterans Affairs, and Related Agencies Appropriations Bill for FY 2027 National Defense Authorization Act, FY27 Other Appropriations issues

Veterans

H.R. 7091, Expanding Veterans Access to Emerging Treatments Act Military Construction, Veterans Affairs, and Related Agencies Appropriations Bill for FY 2027 National Defense Authorization Act, FY27 Other Appropriations issues

 Bills named in this filing 1
  • H.R. 7091
    Expanding Veterans’ Access to Emerging Treatments Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem